Select a medication above to begin.
Evenity (romosozumab-aqqg)
romosozumab
Black Box Warnings .
Potential Myocardial Infarction, Stroke and Cardiovascular Death Risk
may incr. risk of MI, stroke, and cardiovascular death; should not be initiated if MI or stroke w/in 12mo; weigh risk/benefit in pts w/ other cardiovascular risks; D/C if MI or stroke occurs during tx
Adult Dosing .
Dosage forms: INJ (pre-filled syringe): 105 mg per 1.17 mL
Special Note
- [formulation clarification]
- Info: nonproprietary name = romosozumab-aqqg
osteoporosis tx, postmenopausal
- [210 mg SC qmo x12mo]
- Info: for pts w/ osteoporotic fracture hx, w/ multiple fracture risk factors, or have failed or intolerant to other osteoporosis tx; calcium and vitamin D supplementation recommended if inadequate dietary intake
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [not defined]
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.